A Pilot Study of a Remote ADHD Monitoring Program

Description

RAMP is a pilot study examining the use of an Attention-Deficit/Hyperactivity Disorder (ADHD) Monitoring Program during the early stages of treating ADHD in children living in rural settings. This trial will enroll 36 caregiver/infant dyads across 2 sites and will evaluate feasibility endpoints rather than clinical outcomes. Enrolled participants will be randomized 1:1 to the intervention group (RAMP reports) or control group (digital education handouts). The study duration is 10 months, including start-up, enrollment and intervention, and data analysis and manuscript submission.

Conditions

Attention-deficit/Hyperactivity Disorder, ADHD

Talk to us

Study Overview

On this page

Study Details

Study overview

RAMP is a pilot study examining the use of an Attention-Deficit/Hyperactivity Disorder (ADHD) Monitoring Program during the early stages of treating ADHD in children living in rural settings. This trial will enroll 36 caregiver/infant dyads across 2 sites and will evaluate feasibility endpoints rather than clinical outcomes. Enrolled participants will be randomized 1:1 to the intervention group (RAMP reports) or control group (digital education handouts). The study duration is 10 months, including start-up, enrollment and intervention, and data analysis and manuscript submission.

A Pilot Study of a Remote Attention-Deficit/Hyperactivity Disorder Monitoring Program (RAMP) for Children in Rural Areas

A Pilot Study of a Remote ADHD Monitoring Program

Condition
Attention-deficit/Hyperactivity Disorder
Intervention / Treatment

-

Contacts and Locations

Jackson

University of Mississippi Medical Center, Jackson, Mississippi, United States, 39216

Charleston

Medical University of South Carolina, Charleston, South Carolina, United States, 29425

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * be under the care of a participating provider
  • * be aged 5-11 at enrollment
  • * have a diagnosis of ADHD
  • * be initiating stimulant medication for treatment for the first time or have not received stimulant medication for the last 6 months
  • * be attending in-person elementary school
  • * be willing and legally able to give consent
  • * have access to a smartphone
  • * be English-speaking
  • * reside with the child at least 3 days per week
  • * complete an initial symptom assessment prior to starting stimulant treatment and be willing to provide a copy to the study team
  • * manage ADHD care in patients age 5-11 years
  • * provide informed consent
  • * agree to use the RAMP platform if they care for patients randomized to use it
  • * agree to provide information to potential participants about the study and contact the research coordinator if interested
  • * has serious mental health comorbidities (Children with depression, anxiety, oppositional defiant disorder will be permitted to participate. Children with schizophrenia, bipolar disorder, conduct disorder and those who have been hospitalized for any mental health condition will be excluded from the study.)
  • * has severe neurodevelopment disorders (Children with well-controlled seizure disorders will be permitted to participate.)
  • * is currently receiving, or previously received, atypical antipsychotic medication treatment
  • * is or becomes pregnant

Ages Eligible for Study

5 Years to 11 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

IDeA States Pediatric Clinical Trials Network,

Study Record Dates

2025-10-30